Literature DB >> 19584863

Damage control in the nervous system: beware the immune system in spinal cord injury.

Phillip Popovich1, Dana McTigue.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19584863     DOI: 10.1038/nm0709-736

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

Review 1.  Central nervous system injury-induced immune deficiency syndrome.

Authors:  Christian Meisel; Jan M Schwab; Konstantin Prass; Andreas Meisel; Ulrich Dirnagl
Journal:  Nat Rev Neurosci       Date:  2005-10       Impact factor: 34.870

2.  Beta-blockers reduce the risk of early death in ischemic stroke.

Authors:  Tomasz Dziedzic; Agnieszka Slowik; Joanna Pera; Andrzej Szczudlik
Journal:  J Neurol Sci       Date:  2006-11-28       Impact factor: 3.181

3.  Neuroendocrine-immune interactions associated with loss and restoration of immune system function in spinal cord injury and stroke patients.

Authors:  J M Cruse; R E Lewis; G R Bishop; W F Kliesch; E Gaitan
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 4.  Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms.

Authors:  J L Teeling; V H Perry
Journal:  Neuroscience       Date:  2008-07-25       Impact factor: 3.590

Review 5.  Detrimental consequences of brain injury on peripheral cells.

Authors:  Anna Catania; Caterina Lonati; Andrea Sordi; Stefano Gatti
Journal:  Brain Behav Immun       Date:  2009-04-24       Impact factor: 7.217

Review 6.  Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression.

Authors:  H Offner; A A Vandenbark; P D Hurn
Journal:  Neuroscience       Date:  2008-07-01       Impact factor: 3.590

7.  Immune depression syndrome following human spinal cord injury (SCI): a pilot study.

Authors:  T Riegger; S Conrad; H J Schluesener; H-P Kaps; A Badke; C Baron; J Gerstein; K Dietz; M Abdizahdeh; J M Schwab
Journal:  Neuroscience       Date:  2008-08-22       Impact factor: 3.590

8.  Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver.

Authors:  Sandra J Campbell; V Hugh Perry; Fernando J Pitossi; Angus G Butchart; Mariela Chertoff; Sara Waters; Robert Dempster; Daniel C Anthony
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

9.  Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.

Authors:  Konstantin Prass; Christian Meisel; Conny Höflich; Johann Braun; Elke Halle; Tilo Wolf; Karsten Ruscher; Ilya V Victorov; Josef Priller; Ulrich Dirnagl; Hans-Dieter Volk; Andreas Meisel
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

10.  Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial.

Authors:  Hendrik Harms; Konstantin Prass; Christian Meisel; Juliane Klehmet; Witold Rogge; Christoph Drenckhahn; Jos Göhler; Stefan Bereswill; Ulf Göbel; Klaus Dieter Wernecke; Tilo Wolf; Guy Arnold; Elke Halle; Hans-Dieter Volk; Ulrich Dirnagl; Andreas Meisel
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

View more
  25 in total

1.  Dissociated predegenerated peripheral nerve transplants for spinal cord injury repair: a comprehensive assessment of their effects on regeneration and functional recovery compared to Schwann cell transplants.

Authors:  Caitlin E Hill; Danika M Brodak; Mary Bartlett Bunge
Journal:  J Neurotrauma       Date:  2012-08-10       Impact factor: 5.269

Review 2.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

Review 3.  Targeting microvasculature for neuroprotection after SCI.

Authors:  Janelle M Fassbender; Scott R Whittemore; Theo Hagg
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

4.  Spinal Cord Injury Impairs Neurogenesis and Induces Glial Reactivity in the Hippocampus.

Authors:  Ignacio Jure; Luciana Pietranera; Alejandro F De Nicola; Florencia Labombarda
Journal:  Neurochem Res       Date:  2017-03-13       Impact factor: 3.996

5.  Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOS+ macrophages.

Authors:  Dustin J Donnelly; Erin E Longbrake; Todd M Shawler; Kristina A Kigerl; Wenmin Lai; C Amy Tovar; Richard M Ransohoff; Phillip G Popovich
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

6.  Neuroprotective ferulic acid (FA)-glycol chitosan (GC) nanoparticles for functional restoration of traumatically injured spinal cord.

Authors:  Wei Wu; Seung-Young Lee; Xiangbing Wu; Jacqueline Y Tyler; He Wang; Zheng Ouyang; Kinam Park; Xiao-Ming Xu; Ji-Xin Cheng
Journal:  Biomaterials       Date:  2013-12-12       Impact factor: 12.479

Review 7.  Progesterone and vitamin d hormone as a biologic treatment of traumatic brain injury in the aged.

Authors:  Donald G Stein; Milos M Cekic
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

8.  Anti-inflammatory treatments during the chronic phase of spinal cord injury improve locomotor function in adult mice.

Authors:  Sheila A Arnold; Theo Hagg
Journal:  J Neurotrauma       Date:  2011-09-06       Impact factor: 5.269

9.  CD11d Antibody Treatment Improves Recovery in Spinal Cord-Injured Mice.

Authors:  Nicole M Geremia; Feng Bao; Trina E Rosenzweig; Todd Hryciw; Lynne Weaver; Gregory A Dekaban; Arthur Brown
Journal:  J Neurotrauma       Date:  2011-12-20       Impact factor: 5.269

Review 10.  The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury.

Authors:  Jan M Schwab; Yi Zhang; Marcel A Kopp; Benedikt Brommer; Phillip G Popovich
Journal:  Exp Neurol       Date:  2014-08       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.